Trademarkia Logo

Canada

C$
GATTEXA
REGISTERED

on 17 Jun 2019

Last Applicant/ Owned by

Takeda Pharmaceuticals U.S.A., Inc.

500 Kendall StreetCambridge, MA 02142

US

Serial Number

1792917 filed on 25th Jul 2016

Registration Number

TMA1027033 registered on 17th Jun 2019

Registration expiry Date

17th Jun 2029

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

CA

K1P1C3

GATTEXA

Trademark usage description

pharmaceutical preparations for the treatment of gastrointestinal disorders, diseases involving varying levels of calcium in cells and outside cells, Read More

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of gastrointestinal disorders, diseases involving varying levels of calcium in cells and outside cells, namely, hypocalcemia, endocrine disorders, namely, hypoparathyroidism, and bone metabolism disorders.


Classification kind code

10

Mark Details


Serial Number

1792917

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 51
on 1st Dec 2017
Allowance Notice Sent
Submitted for opposition 42
on 16th Aug 2017
Advertised
Submitted for opposition 26
on 27th Jul 2017
Approved
Submitted for opposition 27
on 5th Jun 2017
Approval Notice Sent
Submitted for opposition 22
on 28th Feb 2017
Search Recorded
Submitted for opposition 20
on 28th Feb 2017
Examiner's First Report
Submitted for opposition 135
on 19th Aug 2016
Amendment to Application
Submitted for opposition 31
on 1st Aug 2016
Formalized
Submitted for opposition 30
on 25th Jul 2016
Filed
Submitted for opposition 1
on 25th Jul 2016
Created